Navigation Links
NovaBay(R) Pharmaceuticals to Present at Jesup & Lamont 2009 Growth Stock Conference
Date:7/27/2009

EMERYVILLE, Calif., July 27 /PRNewswire-FirstCall/ -- NovaBay(R) Pharmaceuticals, Inc. (NYSE-AMEX: NBY) (http://www.novabaypharma.com), a clinical stage company developing non-antibiotic anti-infective compounds for the treatment or prevention of a wide range of bacterial, viral and fungal infections, announced today that Ron Najafi, Ph.D., Chairman and Chief Executive Officer, will present at the Jesup & Lamont 2009 Growth Stock Conference organized by the LifeTech Capital Group on Thursday, July 30, 2009 at 9:30 am EDT. The presentation will be held at The Boca Raton Resort & Club in Boca Raton, Florida.

Dr. Najafi will provide a corporate overview and highlight NovaBay's clinical progress, business development strategy and product development candidates. His presentation will:

  • update investors on NovaBay's internal clinical programs in hospital-associated infections and respiratory infections.
  • provide information on NovaBay's recent announcements regarding the initiation of a Phase II clinical trial for the use of NovaBay's lead Aganocide(R) compound, NVC-422, for viral conjunctivitis, which is being conducted by its partner Alcon (NYSE: ACL).
  • review the recently announced partnership with Galderma, the world's leading dermatology company, for development of acne and impetigo products
  • discuss the important collaborative agreement with professors Markus Nagl, M.D. and Waldemar Gottardi, Ph.D. of the Medical University of Innsbruck, Austria, which broadens NovaBay's intellectual property estate, expands its pre-clinical pipeline and advances the development of NovaBay's Aganocide compo
    '/>"/>

SOURCE NovaBay Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Solace Pharmaceuticals Appoints Professor David Julius, Renowned Pain Physiologist, to Scientific Advisory Board
2. OncoGenex Pharmaceuticals Completes $9.5 Million Registered Direct Offering
3. Angiotech Pharmaceuticals, Inc. announces filing of shelf-registration statement
4. Anadys Pharmaceuticals to Report Second Quarter 2009 Financial Results
5. Peregrine Pharmaceuticals to Present at the Jesup & Lamont 2009 Growth Stock & National Sales Conference
6. NewBridge Pharmaceuticals Announces Licensing of Pylera(R) for Middle East, Africa, Turkey & Caspian Region
7. Peregrine Pharmaceuticals Licenses Anti-VEGF Antibodies to Affitech
8. Oramed Pharmaceuticals Reports Positive Results From a Study of Oral Insulin Capsule on Type 1 Diabetic Patients
9. OncoGenex Pharmaceuticals to Raise $9.5 Million Through Sale of Common Stock
10. Idenix Pharmaceuticals Reports Second Quarter and Six Month 2009 Financial Results
11. VIA Pharmaceuticals Receives Anticipated Notice From NASDAQ
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... 20, 2014 Not long ago, it ... should be performed late in the development cycle – ... current regulatory trends suggest that, like many things GxP, ... In recent years, multiple drug sponsors have been required ... specific questions during phase I/II. It’s not only clinical ...
(Date:8/20/2014)... 20, 2014 GraphDB™ 6.0 ... including improvements to the enterprise replication cluster, faster ... Lucene, SOLR and Elasticsearch. This release happens to ... performance triplestore – GraphDB™ was formerly known as ... the only mature enterprise resilient RDF triplestore will ...
(Date:8/19/2014)... , Aug. 19, 2014 A Geisinger ... been nominated for a Centers for Disease Control and ... a major public health concern. Joseph ... is one of a team of researchers nominated for ... C. Shepard Science Award for Data Methods and Study ...
(Date:8/19/2014)... 2014 XenoTech announces an exclusive ... metabolite production from bioactive small molecules. Based ... technology enables convenient and timely assessment of critical ... Vice President of Commercial Operations, Christian Darabant, “the ... risk can be measured directly by comparison with ...
Breaking Biology Technology:Are Extractable and Leachables going Phase-Appropriate? New Webinar Hosted by Xtalks 2Ontotext Improves Its RDF Triplestore, GraphDB™ 6.0: Enterprise Resilience, Faster Loading Speeds and Connectors to Full-Text Search Engines Top the List of Enhancements 2Ontotext Improves Its RDF Triplestore, GraphDB™ 6.0: Enterprise Resilience, Faster Loading Speeds and Connectors to Full-Text Search Engines Top the List of Enhancements 3Ontotext Improves Its RDF Triplestore, GraphDB™ 6.0: Enterprise Resilience, Faster Loading Speeds and Connectors to Full-Text Search Engines Top the List of Enhancements 4Geisinger investigator nominated for federal award 2Geisinger investigator nominated for federal award 3Beyond Metabolite Identification, Testable Quantities Now Offered by XenoTech 2Beyond Metabolite Identification, Testable Quantities Now Offered by XenoTech 3
... pace for healthcare in the Philadelphia suburbs, with unique new capabilities ... ... technologies, IRVINE, Calif., Jan. 10 ... Pulse CO-Oximetry and,Read-Through-Motion & Low Perfusion Pulse Oximetry, have announced the,completion ...
... Alerts for key stocks., Seven Summits Strategic Investments, ... (Note: You may have to copy this link,into your ... Alerts cover the following stocks: Exxon Mobil Corp.,(NYSE: ... MER ), DryShips, Inc. (Nasdaq:,DRYS), Computer Sciences Corp. (NYSE: ...
... 10 Transgene,(Euronext Paris: FR0005175080) announces promising preliminary ... vaccine TG4010,(MVA-MUC1-IL2) as an adjunct to first line ... (NSCLC)., This on-going trial is a randomized, ... efficacy of TG4010 in combination with cisplatin and,gemcitabine ...
Cached Biology Technology:Abington Memorial Hospital Completes System-Wide Conversion to Masimo SET Pulse Oximetry Technology 2Abington Memorial Hospital Completes System-Wide Conversion to Masimo SET Pulse Oximetry Technology 3Abington Memorial Hospital Completes System-Wide Conversion to Masimo SET Pulse Oximetry Technology 4Seven Summits Research Releases Alerts on XOM, MER, DRYS, CSC, and PDLI 2Seven Summits Research Releases Alerts on XOM, MER, DRYS, CSC, and PDLI 3Transgene's Therapeutic Vaccine TG4010 Shows Promising Preliminary Phase IIb Data in Advanced Non-Small Cell Lung Cancer 2Transgene's Therapeutic Vaccine TG4010 Shows Promising Preliminary Phase IIb Data in Advanced Non-Small Cell Lung Cancer 3
(Date:8/19/2014)... It,s not a monkey. It,s not a lemur. It,s ... Meet the Philippine tarsier: a tiny, adorable and downright "cool" ... animals that Americans are familiar with," said Rafe Brown, curator-in-charge ... giant eyes and ears; an extremely cute, furry body; a ... interesting expanded fingers and toe tips that look a bit ...
(Date:8/19/2014)... born with neonatal abstinence syndrome (NAS) secondary to ... going through withdrawal than others, but the underlying ... epigenetic (when genes are turned on or off) ... researchers at Boston University School of Medicine (BUSM) ... of its kind study to identify some of ...
(Date:8/19/2014)... ever had a glass of fizzy soda knows that ... in a finding with wide industrial applications, Princeton researchers ... down into the liquid as well. , "It is ... we were surprised, and fascinated, to discover that when ... injected tiny oil droplets into the water," said Howard ...
Breaking Biology News(10 mins):Philippine tarsier gets boost from Kansas research, and genetic proof of a new variety 2Philippine tarsier gets boost from Kansas research, and genetic proof of a new variety 3In-utero methadone, Subutex exposure could alter gene expression, cause severe Neonatal Abstience Syndrome 2Bubbling down: Discovery suggests surprising uses for common bubbles 2Bubbling down: Discovery suggests surprising uses for common bubbles 3
... bacteria, and like any hardworking homeowner, they have developed ... Berkeley, biologists have found. , In a study of ... its roots, UC Berkeley researchers have shown that the ... than they do to the slackers. Root nodules - ...
... The risk of human bird flu infection is small in Australia ... according to bird medicine specialist Dr Bob Doneley. , "The ... neighbours birds are so infinitesimally small," UQ School of Veterinary Science ... have a light plane hit by a meteor and fall on ...
... now have access to one of the most advanced microscopes ... Facility, opened this fall, is a combination of an atomic ... commercial machine of its kind. , The atomic force microscope ... confocal microscope system by Olympus America Inc. Integration of the ...
Cached Biology News:Plants, too, have ways to manage freeloaders 2Plants, too, have ways to manage freeloaders 3Plants, too, have ways to manage freeloaders 4Expert dispels bird flu paranoia 2
... Trap Time of Flight Mass Analyzer for superior sensitivity, mass accuracy, ... - 25,000 m/z, * Precursor ion selection range: 150 - 4000 ... 5 ppm with internal reference, * Dynamic range: 4 orders of ... ...
... pYD1 Yeast Display Vector is specifically designed ... the surface of Saccharomyces cerevisiae. Displayed proteins ... interact with known or putative ligands. pYD1 ... consists of two domains, Aga1 and Aga2, ...
... Oncostatin M (OSM) is a pleiotropic ... and Kaposis sarcoma cells. OSM inhibits the ... lines, simulates fibroblast, smooth muscle and Kaposis ... cells and low density lipoprotein receptor expression ...
Mouse polyclonal antibody to BTAF1 - BTAF1 RNA polymerase II, B-TFIID transcription factor-associated, 170kDa (Mot1 homolog, S. cerevisiae)...
Biology Products: